Back to Search
ERIC GIBBS, PHARMD, BCPS, CPP
PHARMD, BCPS, CPP
Pharmacist
NPI: 1669621876Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
051-039307(IL)
Research & Publications (20)
A biosensor-based characterization of the affinity maturation of the immune response against interferon-beta and correlations with neutralizing antibodies in treated multiple sclerosis patients.
PMID 18937545·J Interferon Cytokine Res·2008
8-other
The IgG subclass-specificities of anti-IFNbeta antibodies change with time and differ between the IFNbeta products in relapsing remitting multiple sclerosis patients.
PMID 17825927·J Neuroimmunol·2007
4-observational
New graduate RN work satisfaction after completing an interactive nurse residency.
PMID 19359887·J Nurs Adm·2009
8-other
Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy.
PMID 19197364·PLoS Genet·2009
7-preclinical
Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?
PMID 19667022·Mult Scler·2009
4-observational
A resolution by the society for tropical veterinary medicine in support of "one health".
PMID 19120162·Ann N Y Acad Sci·2008
7-preclinical
Malignant melanoma in a multiple sclerosis patient with persistent neutralizing antibodies to interferon-beta.
PMID 18171383·Eur J Neurol·2008
5-case
Validating parameters of a luciferase reporter gene assay to measure neutralizing antibodies to IFNbeta in multiple sclerosis patients.
PMID 18511063·J Immunol Methods·2008
4-observational
Kindlin-2 is an essential component of intercalated discs and is required for vertebrate cardiac structure and function.
PMID 18174465·Circ Res·2008
7-preclinical
Probing the mechanism of insulin aggregation with added metalloporphyrins.
PMID 18220359·Biochemistry·2008
8-other
Reduced effectiveness of long-term interferon-beta treatment on relapses in neutralizing antibody-positive multiple sclerosis patients: a Canadian multiple sclerosis clinic-based study.
PMID 17967840·Mult Scler·2007
8-other
Safety of an attenuated West Nile virus vaccine, live Flavivirus chimera in horses.
PMID 18065304·Equine Vet J·2007
7-preclinical
Comparative efficacies of three commercially available vaccines against West Nile Virus (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model.
PMID 17687109·Clin Vaccine Immunol·2007
4-observational
Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model.
PMID 18065305·Equine Vet J·2007
7-preclinical
Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: implications for adverse metabolic effects.
PMID 17035934·Neuropsychopharmacology·2007
7-preclinical
Establishment of correlation between in vitro enzyme binding potency and in vivo pharmacological activity: application to liver glycogen phosphorylase a inhibitors.
PMID 16537796·J Pharmacol Exp Ther·2006
7-preclinical
During 3 years treatment of primary progressive multiple sclerosis with glatiramer acetate, specific antibodies switch from IgG1 to IgG4.
PMID 16765453·J Neuroimmunol·2006
2-rct
Should neutralizing antibodies be monitored during interferon-beta treatment for multiple sclerosis?
PMID 16932528·Nat Clin Pract Neurol·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1100 TUNNEL RD
ASHEVILLE, NC 28805 - Phone
- (828) 298-7911
Quick Facts
- NPI
- 1669621876
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile